The introduction of the 505(b)(2) application pathway by the USFDA has turned out to be a game-changer for pharma companies. Not only has it led to faster drug approvals compared…
Advances in the oral delivery of protein and peptide therapeutics
Recent advancements in biologics have unleashed tremendous opportunities in addressing unmet medical needs taking healthcare to new heights. Biologics have shown promising results in the treatment of debilitating conditions…